Biotech · Private company
NoNO Inc.
Track this companyFree. Adds NoNO Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NerinetidePhase 3 · Stroke, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- Nerinetide (NA-1), 2.6 mg/kgPhase 3 · Stroke, AcuteClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding ThrombolysisPHASE3 · COMPLETED · started Dec 6, 2020ClinicalTrials.gov NCT04462536 · fetched Nov 12, 2026
- Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for StrokePHASE3 · COMPLETED · started Mar 1, 2017ClinicalTrials.gov NCT02930018 · fetched Nov 12, 2026